Tg(APOE_i3*,APOC1)2Lmh
Transgene Detail
|
Symbol: |
Tg(APOE_i3*,APOC1)2Lmh |
Name: |
transgene insertion 2, Louis M Havekes |
MGI ID: |
MGI:3768068 |
Synonyms: |
apoE3-Leiden, APO*E3-Leiden, APOE*3-Leiden, APOE*3Leiden, APOE*3Leiden-C1, E3L, Tg(APOE*3,APOC1)2Lmh |
Transgene: |
Tg(APOE_i3*,APOC1)2Lmh Location: unknown
|
Alliance: |
Tg(APOE_i3*,APOC1)2Lmh page
|
|
|
Transgene Type: |
|
Transgenic (Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(APOE_i3*,APOC1)2Lmh expresses
2 genes
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
APOC1 (341) |
|
|
human |
APOE (348) |
|
|
|
|
|
Tg(APOE_i3*,APOC1)2Lmh expression driven by
2 genes
Transgene expression driven by:
Organism |
Driver Gene |
Homolog in Mouse |
Note |
human |
APOC1 (341) |
|
|
human |
APOE (348) |
|
|
|
|
|
Mutation details: A construct carrying a 27-kb genomic fragment containing the human APOE*3-Leiden gene and endogenous promoter, the APOCl gene, and the complete intergenic region between APOCl and the APOCl pseudogene, harboring the postulated liver regulatory element, was used to create transgenic mice. The human APOE*3-Leiden mutation is characterized by a tandem duplication of codons 120-126 and yields a mature protein of 306 amino acid residues. This transgenic line carries approximately 4 copies of the transgene. Expression of APOE*3 and APOC1 mRNA and protein is detectable in liver of transgenic mice and not in kidney. Two other transgenic lines, 181 and 195, were also generated.
(J:109205)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
Original: |
J:109205 van den Maagdenberg AM, et al., Transgenic mice carrying the apolipoprotein E3-Leiden gene exhibit hyperlipoproteinemia. J Biol Chem. 1993 May 15;268(14):10540-5 |
All: |
92 reference(s) |
|